Diagnostic faecal calprotectin recommended for MBS reimbursement

The Medical Services Advisory Committee (MSAC) has approved the MBS listing of faecal calprotectin (FP) testing for the differential diagnosis of IBD from IBS in adults and IBD from non-IBD in children. The long-awaited decision is no doubt welcomed by IBD clinicians but tempered by the fact that FC testing will not yet be available ...

Already a member?

Login to keep reading.

© 2021 the limbic